• JiangXi Guo Yao Factory Passes FDA Inspection

News

JiangXi Guo Yao Factory Passes FDA Inspection

ChemWerth, a supplier of active pharmaceutical ingredients to generic drug manufacturers, is pleased to announce that its partner, JiangXi Guo Yao (Guo Yao) pharmaceutical facility has passed an FDA
overseas inspection.

Guo Yao’s main products exported to the US include Lincomycin HCl and Oxytetracycline HCl. ChemWerth and Guo Yao supply Lincomycin HCl worldwide.

ChemWerth and Guo Yao have collaborated since 1987. Guo Yao was one of the first Chinese factories to supply FDA approved Active Pharmaceutical Ingredients (APIs) to the United States. Guo Yao continues to be a primary supplier of high quality APIs to the Chinese and US markets. ChemWerth also reported that the FDA inspection of Guo Yao cited two minor 483 deficiencies, both of which are being promptly addressed at the facility.

According to Mr. Peter Werth, ChemWerth CEO, “We are very pleased that another one of our partner factories has been successful in passing an FDA inspection. Our regulatory expertise in helping manufacturers like Guo Yao get approved is a real value-added benefit for our customers. We’re proud to have Guo Yao as a manufacturing partner for over 22 years.”


Digital Edition

Lab Asia 32.1 Feb 2025

February 2025

Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...

View all digital editions

Events

SPS Smart Production Solutions Guangzhou

Feb 25 2025 Guanghzou, China

SmartLab Exchange

Feb 25 2025 Amsterdam, Netherlands

Nepal Lab

Feb 27 2025 Kathmandu, Nepal

PITTCON 2025

Mar 01 2025 Boston, MA, USA

IFPAC 2025

Mar 02 2025 Bethesda, MD, USA

View all events